Calculating Process Control ROI for Improved Costs and Timelines
Incorporating process analytical technologies (PAT) into a biopharmaceutical manufacturing paradigm can save companies time, resources, and costs. The degree of savings a biopharma can expect from adopting PAT can vary widely and depends upon several factors, from the scale of a process to the value of a drug product, and understanding how multifaceted variables interact to influence PAT selection can help companies identify technology solutions that maximize both quality and cost efficiency.
The primary goal of PAT is to mitigate the risks associated with gaps in data and process understanding. While its widespread deployment across the space has primarily been the result of a drive toward improved product quality, the financial advantages PAT can offer individual companies have largely been ignored. Calculating the return on investment (ROI) for these technologies is integral to establishing a true understanding of the value of PAT as part of an overarching business strategy.
-
Most popular related searches
Customer comments
No comments were found for Calculating Process Control ROI for Improved Costs and Timelines. Be the first to comment!